Cassava Sciences sinks amid fresh allegations against Alzheimer’s studies - Seeking Alpha

4/19/2022 12:00:00 AM3 yearsago
by Dulan Lokuwithana

Alzheimer's drug developer, Cassava Sciences (SAVA) has lost ~18% in the pre-market Tuesday so far after The New York Times detailed new allegations related to the studies of the...

travellinglight/iStock via Getty Images Alzheimer's drug developer, Cassava Sciences (NASDAQ:SAVA) has lost ~18% in the pre-market Tuesday so far after The New York Times detailed new allegations re… [+1639 chars]

full article...